SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-25-002723
Filing Date
2025-01-10
Accepted
2025-01-10 17:00:23
Documents
27
Period of Report
2025-01-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0227364-8k_avalon.htm   iXBRL 8-K 41983
2 CERTIFICATE OF DESIGNATIONS OF PREFERENCES AND RIGHTS OF SERIES D CONVERTIBLE PR ea022736401ex10-1_avalon.htm EX-10.1 41830
3 EXCHANGE AGREEMENT, BETWEEN THE COMPANY AND LU, DATED AS OF JANUARY 9, 2025 ea022736401ex10-2_avalon.htm EX-10.2 25126
4 GRAPHIC ex10-1_001.jpg GRAPHIC 969215
5 GRAPHIC ex10-1_002.jpg GRAPHIC 1116360
6 GRAPHIC ex10-1_003.jpg GRAPHIC 1171363
7 GRAPHIC ex10-1_004.jpg GRAPHIC 1220812
8 GRAPHIC ex10-1_005.jpg GRAPHIC 1277899
9 GRAPHIC ex10-1_006.jpg GRAPHIC 1337972
10 GRAPHIC ex10-1_007.jpg GRAPHIC 912514
11 GRAPHIC ex10-1_008.jpg GRAPHIC 1254038
12 GRAPHIC ex10-1_009.jpg GRAPHIC 395910
13 GRAPHIC ex10-1_010.jpg GRAPHIC 157837
14 GRAPHIC ex10-1_011.jpg GRAPHIC 459348
15 GRAPHIC ex10-1_012.jpg GRAPHIC 362666
  Complete submission text file 0001213900-25-002723.txt   14956816

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE albt-20250106.xsd EX-101.SCH 3039
17 XBRL LABEL FILE albt-20250106_lab.xml EX-101.LAB 34240
18 XBRL PRESENTATION FILE albt-20250106_pre.xml EX-101.PRE 22375
29 EXTRACTED XBRL INSTANCE DOCUMENT ea0227364-8k_avalon_htm.xml XML 3801
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 25523776
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)